Evidence map›Paper›PMID 40076685›Full record

ArticleInternational journal of molecular sciences2025

Comprehensive Assessment of Neuropathy and Metabolic Parameters in Type 1 Diabetic Patients with or Without Using Continuous Glucose Sensors.

Barbara Bordács, Ákos Várkonyi, Zsuzsanna Valkusz, Szabolcs Nyiraty, Anikó Pósa, Adrienn Menyhárt, Csaba Lengyel, Péter Kempler, Krisztina Kupai, Tamás Várkonyi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Barbara BordácsDepartment of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.
Ákos VárkonyiFaculty of Dentistry, University of Szeged, 6720 Szeged, Hungary.
Zsuzsanna ValkuszDepartment of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.
Szabolcs NyiratyDepartment of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.
Anikó PósaFaculty of Dentistry, University of Szeged, 6720 Szeged, Hungary.
Adrienn MenyhártDepartment of Oncology and Internal Medicine, Faculty of Medicine, Semmelweis University, 1083 Budapest, Hungary.
Csaba LengyelDepartment of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.
Péter KemplerDepartment of Oncology and Internal Medicine, Faculty of Medicine, Semmelweis University, 1083 Budapest, Hungary.
Krisztina KupaiDepartment of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.
Tamás VárkonyiDepartment of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.ORCID 0000-0003-2057-7993

Funding

Bolyai Foundation ÚNKP-23-5-SZTE-691 (Kupai K.) and Bolyai János postdoctoral research fellow fund (Kupai K.; bo_683_21), GINOP_PLUSZ-2.1.1-21-2022-00083 and SZTE_SZAOK-KKA_SZAOK-SZBK-2023/5S809 (Kupai K).ÚNKP-23-5-SZTE-691 (Kupai K.) and Bolyai János postdoctoral research fellow fund (Kupai K.; bo_683_21), GINOP_PLUSZ-2.1.1-21-2022-00083 and SZTE_SZAOK-KKA_SZAOK-SZBK-2023/5S809 (Kupai K). ÚNKP-23-5-SZTE-691 (Kupai K.) and Bolyai János postdoctoral research fellow fund (Kupai K.; bo_683_21), GINOP_PLUSZ-2.1.1-21-2022-00083 and SZTE_SZAOK-KKA_SZAOK-SZBK-2023/5S809 (Kupai K).
6 · The paper itself

Abstract

The present study was conducted in type 1 diabetic (T1DM) patients to evaluate the metabolic and glycemic control as well as the manifestations of neuropathy. The impact of continuous glucose monitoring (CGM) on the measured parameters was also analyzed. A total of 61 T1DM patients (age: 42.5 ± 1.8 years, DM duration: 22.8 ± 1.6 years, mean ± SE) participated in the study. In total, 24 patients had CGM sensors and 37 did not. Cardiovascular autonomic neuropathy was assessed using cardiovascular reflex tests. Peripheral sensory function was evaluated by a Neurometer and calibrated tuning fork on the upper and lower limbs. Metabolic status was characterized by the determination of triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, and glycated haemoglobin (HbA

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Diabetic NeuropathiesAdultFemaleGlycated HemoglobinHumansMaleMiddle AgedTriglyceridesBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanTriglyceridesCGMcholesterolcontinuous glucose monitoringdiabetes mellitusneuropathyserum lipidtriglyceride

Identifiers

PMID40076685
PMCPMC11900075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.